Lawood & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
PCA
MSV
BTCPP
VFA
CAM
EB
AIM
FFA
QPBE
Lawood & Co's LLY Position: Q3 2026 in Review
Lawood & Co reduced its Eli Lilly (LLY) stake by 2.4% in Q3 2026, selling an estimated $14.2K and leaving 493 shares worth $570K. The position accounts for 0.39% of the portfolio, ranked #50.
Lawood & Co first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $606K in Q2 2026. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Lawood & Co held 493 shares of Eli Lilly worth $570K as of Q3 2026.
- Lawood & Co sold 12 Eli Lilly shares in Q3 2026, an estimated $14.2K.
- Eli Lilly made up 0.39% of Lawood & Co's portfolio in Q3 2026, its #50 holding.
- Lawood & Co first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Lawood & Co's Eli Lilly position peaked at $606K in Q2 2026.
- 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Lawood & Co's 13F filing for Q3 2026, filed 9 Oct 2026.